Cipla Shares Drop 5% But Trim Losses After USFDA Issues Warning Letter to Goa Unit

The warning letter reportedly said that the pharma company may continue to sell existing drugs from the Goa facility, but newer approvals will be held if corrective measures are not taken.

from Top Business News- News18.com https://ift.tt/2T0t8Kr